Amplify Transformational Data Sharing ETF vs DexCom, Inc. — how do they compare? Amplify Transformational Data Sharing ETF trades at $59.16, while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is trading nearer its 52-week high, Amplify Transformational Data Sharing ETF nearer its low. Which is the better fit depends on your goals.
| BLOK | DXCM | |
|---|---|---|
52-Week High | $74.10 | $89.53 |
52-Week Low | $47.36 | $54.84 |
Market Cap | — | $33.79B |
Sector | — | Health |
Enterprise Value | — | $33.24B |
Trailing returns across standard periods
The fund is an actively managed ETF that seeks to provide total return by investing at least 80% of its net assets in the equity securities of companies actively involved in the development and utilization of "transformational data sharing technologies". It may invest in non-US equity securities, including depositary receipts.
Read more on BLOK →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →